• Rhonda M Cooper-DeHoff, Qian Zhou, Efrain Gaxiola, Jose L Cangiano, David Garcia-Barreto, Eileen Handberg, Carl J Pepine, and INVEST Investigators.
• Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida 32610, USA. dehofrm@medicine.ufl.edu
• J Womens Health (Larchmt). 2007 Jun 1; 16 (5): 632-40.

BackgroundProspective data regarding blood pressure (BP) control and cardiovascular (CV) outcomes in Hispanic women are lacking.MethodsWe analyzed 5017 Hispanic and 4710 non-Hispanic white hypertensive women with coronary artery disease (CAD) in the INternational VErapamil SR/Trandolapril STudy (INVEST) to determine the impact of baseline characteristics and BP control on CV outcomes.ResultsAt baseline, Hispanic women were younger and a had lower prevalence of most established CV risk factors than non-Hispanic white women. At 24 months, BP control (< 140/90 mm Hg) was achieved in 75% of Hispanic and 68% of non-Hispanic white women, (p < 0.001), with most women, regardless of ethnicity, requiring > or =2 antihypertensive agents. Following 26,113 patient-years of follow-up, the primary outcome (first occurrence of nonfatal myocardial infarction [MI], nonfatal stroke, or all cause death) occurred in 5.7% of Hispanic and 12.3% of non-Hispanic white women (adjusted HR = 0.84, 95% CI = 0.71-0.98, p = 0.03). There was no difference in outcome in either group of women comparing the randomized antihypertensive treatment strategies.ConclusionsDespite accounting for a lower risk profile, deployment of protocol-based antihypertensive treatment regimens resulted in superior BP control and fewer CV events in Hispanic women compared with non-Hispanic white women.

29 keywords...

hide…